BEAM vs KEYS · rev $63.5M vs P/E 57, rev $4.98B
Beam Therapeutics Inc (BEAM) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
BEAM currently screens at market cap $2.01B. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the BEAM and KEYS stock pages for the full models.
Not investment advice.